UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
The Shaking Catastrophe: We've already mentioned this, but it bears repeating
L., & Matsumoto, J
A peptide that acts as a positive helper at GABA-A receptors can lower anxiety, and because stress itself taxes working memory, easing that load can indirectly sharpen focus
Supplementing the bees' diet during 21 consecutive days with BPC-157 reduced the damage, in particular, the damage of the outer muscular coat, and increased the survival rate of the colonies in field
What is Peripheral Neuropathy Peripheral neuropathy More than 100 types of peripheral neuropathy have been identified, each with its own symptoms and prognosis